Successful fetal outcome after exposure to idarubicin and cytosine- arabinoside during the second trimester of pregnancy - A case report

American Journal of Perinatology

Volumn 15, Issue 5, 1998, Pages 295-297

  Claahsen, Hedi L ^a   Semmekrot, Ben A ^a   Van Dongen, Pieter W J ^a   Mattijssen, Vera ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Chemotherapeutic agents; Newborn; Pregnancy

Indexed keywords

ASPARTATE AMINOTRANSFERASE; CYTARABINE; IDARUBICIN; LACTATE DEHYDROGENASE;

ACUTE GRANULOCYTIC LEUKEMIA; ARTICLE; CASE REPORT; ERYTHROBLASTOSIS; FEMALE; FETUS OUTCOME; HUMAN; INTRAUTERINE GROWTH RETARDATION; INTRAVENOUS DRUG ADMINISTRATION; NEWBORN; PREMATURITY; PRENATAL EXPOSURE; PRIORITY JOURNAL; SECOND TRIMESTER PREGNANCY;

EID: 0031805649     PISSN: 07351631     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-993946     Document Type: Article

References (9)

1. Doll DC, Ringenberg QS, Yarbro JW. Antineoplastic agents and pregnancy. Semin Oncol 1989;16:337-346
2. Artlich A, Möller J, Tschakaloff A, Schwinger E, Kruse K, Gortner L. Teratogenic effects in a case of maternal treatment for acute myelocytic leukemia - neonatal and infantile course. Eur J Pediatr 1994;153:488-491
3. Wiebe VJ, Sipila PEH. Pharmacology of antineoplastic agents in pregnancy. Critical Rev Oncol Hematol 1994; 16:75-112
4. Reynoso EE, Huerta F. Acute leukemia and pregnancy - fatal fetal outcome after exposure to idarubicin during the second trimester. Acta Oncologica 1994;33:703-716
5. Reynoso EE, Shepherd FA, Messner HA, Farquharson HA, Garvey MB, Baker MA. Acute leukemia in pregnancy. The Toronto Leukemia Group. Experience with long term follow-up of children exposed in utero to chemotherapeutic agents. J Clin Oncol 1987;5:1098-1106
6. Legha SS, Benjamin RS, Mackay B, Ewer M, Wallace S, Valdivieso M, Rasmussen SL, Blumenschein GR, Freireich EJ. Reduction of doxorubicin cardiotoxicity by prolonged continuous intravenous infusion. Ann Int Med 1982;96:133-139
7. Wagner V, Hill J, Weaver D, Baehner R. Congenital abnormalities in baby born to cytarabine treated mother. Lancet ii 1980:98-99
8. Hudson MM, Weinstein HJ, Donaldson SS, Greenwald C, Kun L, Tarbell N, Humpphrey WA, Rupp C, Marina NM, Wilimas J, et al. Acute hypersensitivity reactions to etoposide in a VEPA regimen for Hodgkin's disease. J Clin Oncol 1993; 11:1080-1084
9. Doll DC, Ringenberg QS, Yarbro JW. Management of cancer during pregnancy. Arch Intern Med 1988;148:2058-2064